Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$402K Hold
6,300
﹤0.01% 829
2021
Q1
$300K Sell
6,300
-4,600
-42% -$198K ﹤0.01% 987
2020
Q4
$328K Hold
10,900
﹤0.01% 953
2020
Q3
$235K Sell
10,900
-45,683
-81% -$894K ﹤0.01% 1019
2020
Q2
$1.23M Sell
56,583
-55,760
-50% -$1.03M 0.02% 664
2020
Q1
$1.5M Buy
112,343
+200
+0.2% +$6.74K 0.02% 533
2019
Q4
$5.33M Sell
112,143
-275
-0.2% -$11.4K 0.05% 259
2019
Q3
$4.5M Buy
112,418
+200
+0.2% +$7.72K 0.05% 298
2019
Q2
$4.75M Sell
112,218
-2,098
-2% -$92.7K 0.05% 284
2019
Q1
$5.21M Sell
114,316
-690
-0.6% -$31.6K 0.06% 257
2018
Q4
$5.09M Hold
115,006
0.07% 210
2018
Q3
$5.42M Hold
115,006
0.05% 259
2018
Q2
$4.57M Sell
115,006
-4,193
-4% -$179K 0.05% 322
2018
Q1
$4.84M Sell
119,199
-9,105
-7% -$338K 0.05% 276
2017
Q4
$4.17M Sell
128,304
-138
-0.1% -$3.79K 0.04% 350
2017
Q3
$3.42M Buy
128,442
+97,200
+311% +$2.75M 0.03% 434
2017
Q2
$1.06M Buy
+31,242
New +$1.39M 0.01% 768
2016
Q3
Sell
-5
Closed -$1K 1953
2016
Q2
$1K Hold
5
﹤0.01% 1622
2016
Q1
$1K Hold
5
﹤0.01% 1615
2015
Q4
$1K Buy
+5
New +$289 ﹤0.01% 1642

Other funds holding GCO

QS Investors's GCO Position: Q2 2021 in Review

QS Investors held its Genesco (GCO) position steady in Q2 2021 at 6,300 shares worth $402K. The position accounts for ﹤0.01% of the portfolio, ranked #829.

QS Investors first reported a position in GCO in Q4 2015 and has held it in 20 quarters since. The position peaked at $5.42M in Q3 2018. 148 funds tracked by Wall St. Rank hold GCO as of Q2 2021.

  • QS Investors held 6,300 shares of Genesco worth $402K as of Q2 2021.
  • QS Investors left its Genesco share count unchanged in Q2 2021.
  • Genesco made up ﹤0.01% of QS Investors's portfolio in Q2 2021, its #829 holding.
  • QS Investors first reported a position in Genesco in Q4 2015 and has held it in 20 quarters since.
  • QS Investors's Genesco position peaked at $5.42M in Q3 2018.
  • 148 funds tracked by Wall St. Rank held Genesco as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.